A Harrogate schoolboy receiving treatment for leukaemia is urging people to do two things that could save the lives of people like him.
Harry Brown, 17, says that donating blood and signing up to the Anthony Nolan Stem Cell Register could make the difference between life and death for hundreds of patients, and is calling on anyone eligible to volunteer.
Harry, a sixth former at St Aidan’s CE High School, was diagnosed with a type of blood cancer called acute lymphoblastic leukaemia (ALL) in July this year, and has been receiving intense chemotherapy and immunotherapy at the Teenage Cancer Trust unit at St James’s Hospital in Leeds.
He told the Stray Ferret:
“Unfortunately, I still have some disease left, so will need a stem cell transplant to achieve a cure. This is providing we manage to find a suitable donor.
“I therefore feel it is incredibly important that the Anthony Nolan Stem Cell Register is promoted to as wide an audience as possible as signing up is something very simple that anyone aged 16 to 30 can do but might just save the life of someone with blood cancer like me.
“I also feel that the issue of blood donation requires increased awareness and promotion as I have received countless life-saving platelet and blood transfusions, which can only happen if people donate.
“My message is that you can do something extraordinary – you can save a life by doing two simple things which can make such a huge difference to people like me.”

Harry in the atrium of the Bexley Wing at St James’s Hospital in Leeds.
In the UK, there is a long-standing shortage of blood donors. According to NHS Blood and Transplant, 140,000 new donors are needed each year just to meet demand.
But the rewards are incalculable – in just one hour, a blood donor can save three lives.
Nine out of 10 people joining the Anthony Nolan Stem Cell Register who donate their stem cells do so through their blood within just a few hours; the other 10% donate by giving bone marrow.
Read more:
- St Aidan’s students bring a taste of Italy to Great Yorkshire Show
- Son of Leeds United legend raises funds to beat his own cancer
- Blood testing to move from Harrogate to Knaresborough due to Sainsbury’s pharmacy closure
Before his diagnosis, Harry played the tuba with Tewit Youth Band and volunteered as a Young Leader with 16th Harrogate Scouts, as well as studying for A levels in English language and literature, geography and politics. But he is now taking a break from school while he concentrates on dealing with leukaemia, with the support of his family, friends, and St Aidan’s.
He says that illnesses such as ALL are not just “something that happens to other people”. He said:
“I just felt a bit sick and off-colour, but within a week I’d been diagnosed with ALL.
“Unfortunately, it can happen to anyone when you least expect it. I went from climbing up volcanoes on a school trip to Iceland one week to having an emergency procedure to remove my white blood cells the next.
“Having a cancer diagnosis when you’re young is hard; it tips your life upside-down, and there’s no getting away from that. There were some days where I wondered whether I would have the energy to make it through the day, particularly when I was on daily chemotherapy. But it was people like my clinical nurse specialist and the youth support coordinator who picked me up and motivated me to keep fighting it, one cell at a time.
“It also puts a whole new perspective on life and what is important, and it makes me more determined to see a future where nobody, especially children, has to experience the gruelling treatment of cancer.”
To find out more about giving blood, visit the NHS Give Blood website, and for more information about how to donate stem cells, go to the Anthony Nolan website.
Harrogate man given two weeks to live calls for more blood cancer researchA man from a village near Harrogate who was told he had two weeks to live is backing a research project to find new treatments for cancer.
Stephen Young, 73, who lives in Brackenthwaite, experienced unusual symptoms last summer including a constantly bleeding nose, a rash on his face, mouth ulcers and shortness of breath.
His GP initially treated him for rosacea and gave him a nasal cream, but the symptoms worsened.
When Stephen returned to the doctor, he had blood tests and was offered a chest x-ray – which revealed a major infection in his lungs.
After being sent by ambulance to A&E at Harrogate District Hospital, company chairman Stephen was diagnosed with acute myeloid leukaemia (AML). The blood cancer claims more than 2,600 lives a year in the UK – and Stephen’s case was so advanced he was told that, without treatment, he had just two weeks to live.
He said:
“Treatment began at 2am in the morning on July 2. By 4am, the team had started my first round of chemo and treatment for my chest infection which remained a stubborn complication for a further three weeks.
“It was touch and go whether I would pull through.”
Fortunately, the treatment was effective and, nine months on, Stephen is in remission and is hoping for a stem cell transplant later this year to improve his long-term prognosis.
However, the impact on his life continues. He said:
“AML treatment compromises the immune system and makes you very vulnerable to any and all infections. The threat of sepsis is ever-present.
“The need for social distancing between me and my loved ones, and being unable to hug and play with my grandchildren is, for me, AML’s greatest torment.”
Read more:
- Harrogate couple run 127 miles in aid of Motor Neurone Disease charity
- Ex-soldier to walk 104km in a day for homelessness charity
With World AML Day being marked next Friday, April 21, Leukaemia UK is calling on people to help fund more research into the disease and improve the survival rates. Chief executive Fiona Hazell said:
“Important discoveries are happening all the time within leukaemia research.
“With just 15% of AML patients surviving longer than five years after their diagnosis, it’s clear that more effective, kinder, targeted treatments are critically needed. At Leukaemia UK, we know that research has the power to one day stop leukaemia devastating lives.”
Funding from Leukaemia UK has already helped Dr Konstantinos Tzelepis at a research team at the University of Cambridge to discover a new drug which targets a key protein involved in AML growth and survival.
The charity has now announced funding for a new project which will look at ways to target another protein in the disease.
Stephen’s wife Eugenie said:
“We were completely traumatised when the doctor told us Steve had acute myeloid leukaemia. That’s why I am so committed to joining the campaign to raise awareness about blood cancer symptoms.
“The earlier the disease is spotted the better the chance of successful treatment, prognosis and quality of life.”
As well as helping to fund research, Leukaemia UK is urging people to be aware of the symptoms and visit their GP if they are concerned. Diagnosis can often be delayed, frequently happening in A&E when a patient is severely unwell, because the signs can be confused with other, more common symptoms.
Ms Hazell added:
“As with many diseases, earlier diagnosis improves the chances of successful treatment.
“We want to encourage people to trust their instincts when something is wrong and visit their GP to push for that all important blood test, which is the only way to properly diagnose AML.”
